Showing results (71-80 of 82) with videos related to
Sort By:
Pageof 9
Chemical Communications (Cambridge, England)|May 14, 2009
Self-assembly of a bis(adeninyl)-Cu(I) complex: a cationic nucleobase duplex mimicMiguel A Galindo, David Amantia, William Clegg, et al.Leukemia & Lymphoma|August 10, 1999
Combined results of two phase II studies of Taxol (paclitaxel) in patients with relapsed or refractory lymphomasP Goss, A K Stewart, F Couture, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1994
Comparison of the selective aromatase inhibitor formestane with tamoxifen as first-line hormonal therapy in postmenopausal women with advanced breast cancerR Pérez Carrión, V Alberola Candel, F Calabresi, et al.The Journal of Physical Chemistry Letters|July 19, 2020
An Ultrafast Shakedown Reveals the Energy Landscape, Relaxation Dynamics, and Concentration of the N3VH0 Defect in DiamondDaniel J L Coxon, Michael Staniforth, Ben G Breeze, et al.Physical Review Letters|August 29, 2014
Extended point defects in crystalline materials: Ge and SiN E B Cowern, S Simdyankin, C Ahn, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 16, 2000
Phase III comparative study of vinorelbine combined with doxorubicin versus doxorubicin alone in disseminated metastatic/recurrent breast cancer: National Cancer Institute of Canada Clinical Trials Group Study MA8B Norris, K I Pritchard, K James, et al.Physical Review Letters|December 5, 2025
Hot-Phonon-Induced Distortion of Diamond Defects on Ultrafast TimescalesTerng Junn Keat, Jiahui Zhao, Jack M Woolley, et al.Breast Cancer Research and Treatment|February 9, 2017
Safety and immunogenicity of neoadjuvant treatment using WT1-immunotherapeutic in combination with standard therapy in patients with WT1-positive Stage II/III breast cancer: a randomized Phase I studyM Higgins, G Curigliano, V Dieras, et al.Journal of the National Cancer Institute|July 21, 1999
Prevalence and penetrance of BRCA1 and BRCA2 gene mutations in unselected Ashkenazi Jewish women with breast cancerE Warner, W Foulkes, P Goodwin, et al.Nature Genetics|May 1, 1996
Mutation analysis of the BRCA2 gene in 49 site-specific breast cancer familiesC M Phelan, J M Lancaster, P Tonin, et al.Pageof 9